Estrella Immunopharma (ESLA) Cash from Investing Activities (2021 - 2023)
Estrella Immunopharma (ESLA) posted quarterly Cash from Investing Activities of $5.1 million for Q4 2023, up 4617.4% quarter-over-quarter from -$112298.0 in Q3 2023.
Estrella Immunopharma (ESLA) Cash from Investing Activities (2021 - 2023) Analysis & Trends
Estrella Immunopharma (ESLA) has reported Cash from Investing Activities for 2 consecutive years, with $5.1 million the latest figure, recorded in Q4 2023.
- In Q4 2023, Cash from Investing Activities changed N/A year-over-year to $5.1 million; the TTM figure through Jun 2024 stood at $5.0 million (up 111.8% YoY), while the FY2024 annual figure was $5.0 million, up 1916.65% from the prior year.
- Cash from Investing Activities rose to $5.1 million in Q4 2023 per ESLA's latest filing, from -$112298.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $5.1 million in Q4 2023 and bottomed at -$42.0 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | Estrella Immunopharma | 32.29 Mn | 32.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 5.07 Mn |
| Dec 31, 2023 | 5.07 Mn |
| Sep 30, 2023 | -112,298.00 |
| Sep 30, 2023 | -112,298.00 |
| Jun 30, 2023 | 99,204.00 |
| Jun 30, 2023 | 99,204.00 |
| Mar 31, 2023 | -136,533.00 |
| Mar 31, 2023 | -136,533.00 |
| Sep 30, 2021 | -42.00 Mn |
| Sep 30, 2021 | -42.00 Mn |